Melanoma Field Continues to Shift With Targeted Therapy, Immunotherapy Approvals

Joseph Stilwill, MD, addresses recent advances in melanoma and the focus of research moving forward.

More From BioPortfolio on "Melanoma Field Continues to Shift With Targeted Therapy, Immunotherapy Approvals"